Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease
β Scribed by Anna Negroni; Laura Stronati; Maria Pierdomenico; Donatella Tirindelli; Giovanni Di Nardo; Valentina Mancini; Giulia Maiella; Salvatore Cucchiara
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 353 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
β¦ Synopsis
Background: NOD2 is an intracellular protein involved in host recognition of specific bacterial molecules and is genetically associated with several inflammatory diseases, including Crohn's disease (CD). NOD2 stimulation activates the transcription factor, NF-B, through RIP2, a caspase-recruitment domain-containing kinase. NOD2/RIP2 signaling also mediates the activation of antimicrobial peptides such as human β£-defensin 5 (HD-5) and human β£-defensin 6 (HD-6), both produced by Paneth cells. The present study is aimed at describing the downstream events triggered specifically by NOD2 induction in order to demonstrate that the protein, other than overexpressed, is also physiologically associated with RIP2 and Erbin in the bioptic intestinal inflamed specimens of children affected by CD.
Methods: Fifteen children with CD and 10 children used as controls were entered in the study. Mucosal biopsy specimens were taken during endoscopy and mRNA and protein expressions were detected by using real-time polymerase chain reaction and Western blot.
Results: NOD2 is able to form an immunocomplex with the kinase RIP2. As compared to controls, in the inflamed mucosa of patients both mRNA and protein expression levels of RIP2 are increased, and its active phosphorylated form is overexpressed.
Conclusions:
In this study we provide for the first time ex vivo evidence of physiologically relevant protein interactions with NOD2, which are able to trigger the innate immune response in intestinal mucosal specimens of children with CD.
π SIMILAR VOLUMES
## Background: Both antibodies to saccharomyces cerevisiae (asca) and carriage of two mutated nod2/card15 alleles are associated with ileal crohn's disease (cd) and complications requiring bowel surgery. we assessed the asca titer as a marker of cd clinical behavior. ## Methods: In a cross-sectio
## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in
Background: IBD5, IL23R, and ATG16L1 genetic variations are established Crohn's disease (CD) risks alleles. We evaluated these in a population-based case-control study within a cohort to determine their penetrance, population attributable risk, independence, and relationship to other established CD
## Background: Distinct crohn's disease (cd) phenotypes correlate with antibody reactivity to microbial antigens. we examined the association between antibody response to 2 new flagellins called a4-fla2 and fla-x, anti-saccharomyces cerevisiae antibodies (asca), anti-neutrophil cytoplasmic antibodi
## Background: Observational studies have linked crohn's disease (cd) to an increased risk of venous thromboembolic complications. case reports of ischemic stroke in cd patients have raised the question of a similar association, but data from observational studies are lacking. ## Methods: Using d